<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04658329</url>
  </required_header>
  <id_info>
    <org_study_id>ANRS CO5 VIH-2</org_study_id>
    <nct_id>NCT04658329</nct_id>
  </id_info>
  <brief_title>Cohorte Nationale VIH-2</brief_title>
  <acronym>ANRS CO VIH2</acronym>
  <official_title>Cohorte ANRS CO5 &quot;Cohorte Nationale VIH2&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ANRS, Emerging Infectious Diseases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ANRS, Emerging Infectious Diseases</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The HIV2 study is an open cohort of prospective, multicentric, national observation. The main&#xD;
      objective is to study HIV-2 infection in adult patients followed in France.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives are :&#xD;
&#xD;
        -  Describe the epidemiological and clinical characteristics of participants infected with&#xD;
           HIV-2, and the immuno-virological characteristics of the infection.&#xD;
&#xD;
        -  To study the clinical and immunological progression of HIV-2 infection and the&#xD;
           prognostic factors of this evolution.&#xD;
&#xD;
        -  Study the response to antiretroviral treatment (clinical, immuno-virological) and&#xD;
           contribute to the identification of the antiretroviral strategies and combinations most&#xD;
           suited to the particularities of the infection.&#xD;
&#xD;
        -  Allow an evaluation of the care practices of participants followed in French hospitals&#xD;
&#xD;
        -  Provide a bank of clinical-biological data and samples allowing the performance of&#xD;
           virological and / or immunological studies on HIV-2 infection.&#xD;
&#xD;
      The follow-up of the participants is different according to the therapeutic status of the&#xD;
      participants, naive of antiretroviral treatment or already treated with antiretrovirals.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 1994</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Study HIV-2 infection rate in adult patients followed in France</measure>
    <time_frame>At the baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The clinical progression of patients infected HIV-2 evaluate by samples: biological examinations</measure>
    <time_frame>Up to 25 years</time_frame>
    <description>Every 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The epidemiological parameters and progression of patients infected with HIV-2 evaluate by a questionnaire</measure>
    <time_frame>Up to 25 years</time_frame>
    <description>Every 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate of immuno-virological charge of the infection evaluate by serology samples</measure>
    <time_frame>Up to 25 years</time_frame>
    <description>Every 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pourcentage of patient with HIV-2</measure>
    <time_frame>Up to 25 years</time_frame>
    <description>The prognostic factors of patient evolution are evaluate by biological samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pourcentage of response to antiretroviral treatment evaluate by serology samples</measure>
    <time_frame>Up to 25 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pourcentage of good management practices of patients followed in French hospitals evaluate by results</measure>
    <time_frame>Up to 25 years</time_frame>
    <description>During the procedure</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1185</enrollment>
  <condition>HIV-2 Infection</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antiretroviral</intervention_name>
    <description>Study the response to antiretroviral treatment (clinical, immuno-virological) and contribute to the identification of the antiretroviral strategies and combinations most suited to the particularities of the infection.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        HIV-2 infection only followed in consultation or hospitalization in one of the&#xD;
        participating centers in France&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  HIV-2 infection only, diagnosed by ELISA, confirmed by Western-Blot test,&#xD;
&#xD;
          -  Follow-up in consultation or hospitalization in one of the investigating centers,&#xD;
&#xD;
          -  Age greater than or equal to 18 years,&#xD;
&#xD;
          -  Prolonged follow-up possible, residence in France planned for at least one year,&#xD;
&#xD;
          -  Consent to participate,&#xD;
&#xD;
          -  Long-term medical care possible for the participant, or by medical aid (AME), or&#xD;
             declaration of obtaining AME at the time of inclusion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  HIV-1 infection&#xD;
&#xD;
          -  Double HIV-1 + HIV-2 seropositivity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François Dabis, Pr, MD</last_name>
    <role>Study Director</role>
    <affiliation>ANRS, Emerging Infectious Diseases</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sophie Matheron, Pr, MD</last_name>
    <phone>01 40 25 72 39</phone>
    <email>sophie.matheron@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie Longobardi</last_name>
    <phone>05 57 57 48 12</phone>
    <email>julie.longobardi@u-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre hospitalier Victor Dupouy</name>
      <address>
        <city>Argenteuil</city>
        <zip>95100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe PG GENET, MD</last_name>
      <phone>+33.1.34.23.20.63</phone>
      <email>philippe.genet@ch-argenteuil.fr</email>
    </contact>
    <contact_backup>
      <last_name>Juliette JG GERBE</last_name>
      <phone>+33.1.34.23.22.18</phone>
      <email>juliette.gerbe@ch-argenteuil.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Avicenne</name>
      <address>
        <city>Bobigny</city>
        <zip>93000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier OB BOUCHAUD, PhD</last_name>
      <phone>+33.1.48.95.54.21</phone>
      <email>olivier.bouchaud@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>MOHAMED KASSIM MKY YOUSSOUF, MD</last_name>
      <phone>+33.1.48.95.71.94</phone>
      <email>mohamedkassim.youssouf@aphp.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint André</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Morlat, Pr</last_name>
    </contact>
    <investigator>
      <last_name>Philippe Morlat, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Medecine Interne Hopital Antoine Beclere</name>
      <address>
        <city>Clamart</city>
        <zip>92140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francois Boue, MD</last_name>
      <email>francois.boue@abc.ap-hop-paris.fr</email>
    </contact>
    <investigator>
      <last_name>Francois Boue, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Louis Mourier</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Mortier, MD</last_name>
    </contact>
    <investigator>
      <last_name>Emmanuel Mortier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Sud Francilien</name>
      <address>
        <city>Corbeil-essonnes</city>
        <zip>91106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Amélie Chabrol, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Daniel Lelievre, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Daniel Lelievre, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Médecine interne - Centre Hospitalier Intercommunal</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie GARRAIT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Valérie GARRAIT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Djamila MAKHLOUFI</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de La Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent COTTE</last_name>
    </contact>
    <investigator>
      <last_name>Laurent COTTE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Marc LABAUNE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier François Quesnay</name>
      <address>
        <city>Mantes la Jolie</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed JABBAR</last_name>
    </contact>
    <investigator>
      <last_name>Ahmed JABBAR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Gui de Chaudiac</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques Reynes</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de l'Hotel Dieu</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François RAFFI</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel Molina, Pr</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Michel Molina, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Caroline Meyohas, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital la Pitié Salpétrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Roland Tubiana, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Medecine Interne Hopital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Salmon, MD</last_name>
      <email>dominique.salmon@cch.ap-hop-paris.fr</email>
    </contact>
    <investigator>
      <last_name>Dominique Salmon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Bichat - Claude Bernard</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sophie Matheron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pialloux Gilles, Pr</last_name>
      <email>gilles.pialoux@tnn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Gilles Pialloux, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Hôtel Dieu</name>
      <address>
        <city>Paris</city>
        <zip>75181</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Paul Viard, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Paul Viard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agathe Rami, Dr</last_name>
      <email>agathe.rami@lrb.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Rami Agathe, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital du Kremlin Bicêtre Service de médecine interne</name>
      <address>
        <city>Paris</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile Goujard, MD</last_name>
      <phone>+33 1 45 21</phone>
      <phone_ext>25 77</phone_ext>
      <email>cecile.goujard@bct.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Cécile Goujard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier René Dubos</name>
      <address>
        <city>Pontoise</city>
        <zip>95301</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent BLUM</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cedric Arvieux, Dr</last_name>
      <email>cedric.arvieux@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Cedric Arvieux, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI Poissy Saint Germain en Laye</name>
      <address>
        <city>Saint Germain en Laye</city>
        <zip>78105</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves Welker, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yves Welker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Delafontaine</name>
      <address>
        <city>Saint-Denis</city>
        <zip>93205</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Aude KHUONG</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Bretonneau - Service des Maladies Infectieuses</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Bernard, PH</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital André Mignot</name>
      <address>
        <city>Versailles</city>
        <zip>78157</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alix Greder-Belan, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alix Greder-Belan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI Villeneuve Saint Georges</name>
      <address>
        <city>Villeneuve Saint Georges</city>
        <zip>94195</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Patey, MD</last_name>
      <phone>+33 (0)1 43 86 21 62</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>August 5, 2020</study_first_submitted>
  <study_first_submitted_qc>December 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2020</study_first_posted>
  <last_update_submitted>December 1, 2020</last_update_submitted>
  <last_update_submitted_qc>December 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>virus</keyword>
  <keyword>HIV</keyword>
  <keyword>cohort</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Retroviral Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

